Form 4 for ACAD ACADIA PHARMACEUTICALS INC
Accepted 2025-05-19 00:00:00 ET · period of report 2025-05-16 · accession 0001415889-25-013741 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-19 | 2025-05-16 | ACAD | Schneyer Mark C. | EVP, CFO | S - Sale | $25.00 | -2,000 | 62.1K | -3% | -$50.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-16 | S | D | 2,000 | $25.00 | 62,130 | D | — | — | (F2) Includes 1,357 shares of the Issuer's common stock acquired by the Reporting Person on May 15, 2025 pursuant to an employee stock purchase plan. |